World's Best Scientists 2026 revealed!
Roberto Pellicciari

Roberto Pellicciari

D-Index & Metrics

Chemistry

D-Index
67
Citations
18643
World Ranking
6813
National Ranking
160

Biology and Biochemistry

D-Index
70
Citations
21438
World Ranking
6916
National Ranking
163

Overview

Roberto Pellicciari is affiliated with the University of Perugia in Italy and has pursued research primarily within the fields of Biochemistry, Genetics and Molecular Biology, as well as Medicine. Their work spans a range of subfields including Molecular Biology, Biological Psychiatry, Spectroscopy, Oncology, and Immunology.

Their research has focused notably on topics such as Tryptophan and brain disorders, Computational Drug Discovery Methods, Analytical Chemistry and Chromatography, Immune Cell Function and Interaction, Stress Responses and Cortisol, Advanced NMR Techniques and Applications, and Cancer-related Molecular Pathways.

Pellicciari has authored several papers with a citation record indicating engagement in immunoregulatory enzymes, neuroinflammation, and viral replication inhibition, among other areas. Selected recent publications include:

  • "Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme" (2021) published in FEBS Journal
  • "Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation" (2020) published in Proceedings of the National Academy of Sciences
  • "3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine" (2021) published in Nature Communications
  • "The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro" (2022) published in Microorganisms
  • "Class IA PI3Ks regulate subcellular and functional dynamics of IDO1" (2020) published in EMBO Reports

Frequent collaborators in their research activities include Elisa Bianconi, Alice Coletti, Andrea Carotti, Ciriana Orabona, and Roccaldo Sardella.

Pellicciari's work has been featured multiple times in several academic venues, demonstrating a pattern of publication in journals such as:

  • European Journal of Medicinal Chemistry
  • ChemMedChem
  • International Journal of Molecular Sciences
  • Nature Communications
  • Frontiers in Immunology

Best Publications

  • TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis

    Charles W. Thomas;Antimo Gioiello;Lilia G Noriega;Lilia G Noriega;Axelle Strehle

  • Targeting bile-acid signalling for metabolic diseases

    Charles Thomas;Roberto Pellicciari;Mark Pruzanski;Johan Auwerx

  • 6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity

    Roberto Pellicciari;Stefano Fiorucci;Emidio Camaioni;Carlo Clerici

  • Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities

    Robert Schwarcz;Roberto Pellicciari

  • TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading.

    Thijs Pols;Mitsunori Nomura;Taoufiq Harach;Giuseppe Lo Sasso

  • Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors

    Elisabet Wahlberg;Tobias Karlberg;Ekaterina Kouznetsova;Ekaterina Kouznetsova;Natalia Markova;Natalia Markova

  • The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis

    Stefano Fiorucci;Elisabetta Antonelli;Giovanni Rizzo;Barbara Renga

  • De novo NAD + synthesis enhances mitochondrial function and improves health

    Elena Katsyuba;Adrienne Mottis;Marika Zietak;Marika Zietak;Francesca De Franco

  • Structural Basis for Bile Acid Binding and Activation of the Nuclear Receptor FXR

    Li Zhi Mi;Srikripa Devarakonda;Joel M. Harp;Qing Han

  • Bile Acids Signal via TGR5 to Activate Intestinal Stem Cells and Epithelial Regeneration

    Giovanni Sorrentino;Alessia Perino;Ece Yildiz;Gaby El Alam

  • Novel Potent and Selective Bile Acid Derivatives as TGR5 Agonists: Biological Screening, Structure−Activity Relationships, and Molecular Modeling Studies

    Hiroyuki Sato;Antonio Macchiarulo;Charles Thomas;Antimo Gioiello

  • Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure−Activity Relationship of a Series of Body and Side Chain Modified Analogues of Chenodeoxycholic Acid

    Roberto Pellicciari;Gabriele Costantino;Emidio Camaioni;Bahman M. Sadeghpour

  • Discovery of 6α-Ethyl-23(S)-methylcholic Acid (S-EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity

    Roberto Pellicciari;Antimo Gioiello;Antonio Macchiarulo;Charles Thomas;Charles Thomas

  • Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid x receptor ligand, in estrogen-induced cholestasis

    Stefano Fiorucci;Carlo Clerici;Elisabetta Antonelli;Stefano Orlandi

  • A Farnesoid X Receptor-Small Heterodimer Partner Regulatory Cascade Modulates Tissue Metalloproteinase Inhibitor-1 and Matrix Metalloprotease Expression in Hepatic Stellate Cells and Promotes Resolution of Liver Fibrosis

    Stefano Fiorucci;Giovanni Rizzo;Elisabetta Antonelli;Barbara Renga

  • Cross-Talk between Farnesoid-X-Receptor (FXR) and Peroxisome Proliferator-Activated Receptor γ Contributes to the Antifibrotic Activity of FXR Ligands in Rodent Models of Liver Cirrhosis

    Stefano Fiorucci;Giovanni Rizzo;Elisabetta Antonelli;Barbara Renga

  • TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation

    Alessia Perino;Thijs Willem Hendrik Pols;Mitsunori Nomura;Sokrates Stein

  • Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities

    R. Carpenedo;A. Chiarugi;P. Russi;G. Lombardi

  • Pharmacological Characterization of 1-Aminoindan-1,5-dicarboxylic Acid, a Potent mGluR1 Antagonist

    Flavio Moroni;Grazia Lombardi;Christian Thomsen;Patrizia Leonardi

  • The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.

    Giovanni Rizzo;Moises Disante;Andrea Mencarelli;Barbara Renga

  • 1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors.

    Roberto Pellicciari;Roberto Luneia;Gabriele Costantino;Maura Marinozzi

Frequent Co-Authors

Flavio Moroni
Flavio Moroni University of Florence
Aldo Roda
Aldo Roda University of Bologna
Massimo Curini
Massimo Curini University of Perugia
Kristina Schoonjans
Kristina Schoonjans École Polytechnique Fédérale de Lausanne
Robert Schwarcz
Robert Schwarcz University of Maryland, Baltimore
Johan Auwerx
Johan Auwerx École Polytechnique Fédérale de Lausanne
Stefano Fiorucci
Stefano Fiorucci University of Perugia
Antonio Morelli
Antonio Morelli University of Perugia
Alberto Chiarugi
Alberto Chiarugi University of Florence
Kenneth D. R. Setchell
Kenneth D. R. Setchell Cincinnati Children's Hospital Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Roberto Pellicciari

Trending Scientists

Recently Published Articles